Skip to main content

Peer Review reports

From: Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis

Original Submission
30 Aug 2024 Submitted Original manuscript
15 Sep 2024 Reviewed Reviewer Report - Timothy R. Koch
18 Sep 2024 Reviewed Reviewer Report
22 Sep 2024 Reviewed Reviewer Report
25 Sep 2024 Author responded Author comments - Afukonyo Shidoiku Daniel
2 Oct 2024 Reviewed Reviewer Report - Timothy R. Koch
3 Oct 2024 Reviewed Reviewer Report - Payam Khalili
4 Oct 2024 Reviewed Reviewer Report - Shahjada Selim
5 Oct 2024 Reviewed Reviewer Report
10 Oct 2024 Reviewed Reviewer Report
25 Oct 2024 Author responded Author comments - Afukonyo Shidoiku Daniel
Resubmission - Version 2
25 Sep 2024 Submitted Manuscript version 2
26 Oct 2024 Author responded Author comments - Afukonyo Shidoiku Daniel
Resubmission - Version 3
26 Oct 2024 Submitted Manuscript version 3
28 Oct 2024 Author responded Author comments - Afukonyo Shidoiku Daniel
Resubmission - Version 4
28 Oct 2024 Submitted Manuscript version 4
30 Oct 2024 Reviewed Reviewer Report - Shahjada Selim
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
4 Nov 2024 Editorially accepted
18 Nov 2024 Article published 10.1186/s12902-024-01775-2

You can find further information about peer review here.

Back to article page